These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33908707)

  • 1. Cellular Uptake of the ATSM-Cu(II) Complex under Hypoxic Conditions.
    Walke GR; Meron S; Shenberger Y; Gevorkyan-Airapetov L; Ruthstein S
    ChemistryOpen; 2021 Apr; 10(4):486-492. PubMed ID: 33908707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
    Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
    Oncol Rep; 2015 Sep; 34(3):1379-87. PubMed ID: 26134305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
    Oh M; Tanaka T; Kobayashi M; Furukawa T; Mori T; Kudo T; Fujieda S; Fujibayashi Y
    Nucl Med Biol; 2009 May; 36(4):419-26. PubMed ID: 19423010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM.
    Handley MG; Medina RA; Mariotti E; Kenny GD; Shaw KP; Yan R; Eykyn TR; Blower PJ; Southworth R
    J Nucl Med; 2014 Mar; 55(3):488-94. PubMed ID: 24421288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of Cellular Reduction Potential Will Change
    Floberg JM; Wang L; Bandara N; Rashmi R; Mpoy C; Garbow JR; Rogers BE; Patti GJ; Schwarz JK
    J Nucl Med; 2020 Mar; 61(3):427-432. PubMed ID: 31586008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
    Lohith TG; Kudo T; Demura Y; Umeda Y; Kiyono Y; Fujibayashi Y; Okazawa H
    J Nucl Med; 2009 Dec; 50(12):1948-53. PubMed ID: 19910425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluations of a hydrophilic 64Cu-bis(thiosemicarbazonato)-glucose conjugate for hypoxia imaging.
    Bayly SR; King RC; Honess DJ; Barnard PJ; Betts HM; Holland JP; Hueting R; Bonnitcha PD; Dilworth JR; Aigbirhio FI; Christlieb M
    J Nucl Med; 2008 Nov; 49(11):1862-8. PubMed ID: 18927340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.
    Hueting R; Kersemans V; Cornelissen B; Tredwell M; Hussien K; Christlieb M; Gee AD; Passchier J; Smart SC; Dilworth JR; Gouverneur V; Muschel RJ
    J Nucl Med; 2014 Jan; 55(1):128-34. PubMed ID: 24337603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.
    Bonnitcha PD; Bayly SR; Theobald MB; Betts HM; Lewis JS; Dilworth JR
    J Inorg Biochem; 2010 Feb; 104(2):126-35. PubMed ID: 19932509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron emission.
    McMillan DD; Maeda J; Bell JJ; Genet MD; Phoonswadi G; Mann KA; Kraft SL; Kitamura H; Fujimori A; Yoshii Y; Furukawa T; Fujibayashi Y; Kato TA
    J Radiat Res; 2015 Sep; 56(5):784-91. PubMed ID: 26251463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
    Yuan H; Schroeder T; Bowsher JE; Hedlund LW; Wong T; Dewhirst MW
    J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
    Dehdashti F; Grigsby PW; Mintun MA; Lewis JS; Siegel BA; Welch MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1233-8. PubMed ID: 12654432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiobiological effects of hypoxia-dependent uptake of 64Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells.
    Weeks AJ; Paul RL; Marsden PK; Blower PJ; Lloyd DR
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):330-8. PubMed ID: 19915836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
    Yoshii Y; Furukawa T; Matsumoto H; Yoshimoto M; Kiyono Y; Zhang MR; Fujibayashi Y; Saga T
    Cancer Lett; 2016 Jun; 376(1):74-82. PubMed ID: 26996296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.
    Burgman P; O'Donoghue JA; Lewis JS; Welch MJ; Humm JL; Ling CC
    Nucl Med Biol; 2005 Aug; 32(6):623-30. PubMed ID: 16026709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation.
    Yoshii Y; Yoneda M; Ikawa M; Furukawa T; Kiyono Y; Mori T; Yoshii H; Oyama N; Okazawa H; Saga T; Fujibayashi Y
    Nucl Med Biol; 2012 Feb; 39(2):177-85. PubMed ID: 22033022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.